Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells

Neuroscience Bulletin

Volumn 24, Issue 3, 2008, Pages 125-132

  Wang, Ran ^a   Qing, Hong ^a   Liu, Xiao Qian ^a   Zheng, Xiao Lin ^a   Deng, Yu Lin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Dopamine; Fe2+; N methyl salsolinol; Oxidative stress; Parkinson's disease; Salsolinol

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CATECHOL; DOPAMINE; HYDROXYL RADICAL; IRON; LACTATE DEHYDROGENASE; MALONALDEHYDE; N METHYLSALSOLINOL; NEUROTOXIN; QUINOLONE DERIVATIVE; SALICYLIC ACID; SALSOLINOL; THIOBARBITURIC ACID;

APOPTOSIS; ARTICLE; BIOASSAY; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; ELECTROCHEMICAL ANALYSIS; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; LIPID PEROXIDATION; MEDICAL RESEARCH; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSONISM;

APOPTOSIS; CATECHOLS; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYL RADICAL; IRON; IRON METABOLISM DISORDERS; ISOQUINOLINES; MALONDIALDEHYDE; MODELS, BIOLOGICAL; NERVE DEGENERATION; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; PARKINSON DISEASE; SALSOLINE ALKALOIDS; UP-REGULATION;

EID: 47649120835     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-008-1214-z     Document Type: Article

References (26)

1. E.C. Theil 1987 Ferritin: structure, gene regulation and cellular function in animals, plants and microorganisms Annu Rev Biochem 56 289 315
2. D. Berg G. Becker P. Riederer O. Riess 2002 Iron in neurodegenerative disorders Neurotox Res 4 637 653
3. M.E. Götz K. Double M. Gerlach M.B. Youdim P. Riederer 2004 The relevance of iron in the pathogenesis of Parkinson's disease Ann N Y Acad Sci 1012 193 208
4. U. Walter M. Wittstock R. Benecke D. Dressler 2002 Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease J Neural Transm 109 191 196
5. D. Berg M. Gerlach M.B. Youdim K.L. Double L. Zecca P. Riederer 2001 Brain iron pathways and their relevance to Parkinson's disease J Neurochem 79 225 236
6. S. Fahn G. Cohen 1992 The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Ann Neurol 32 804 812
7. P. Jenner 1998 Oxidative mechanism in nigral cell death in Parkinson's disease Mov Disord 13 Suppl1 24 34
8. M. Gerlach D. Ben-Shachar P. Riederer M.B. Youdim 1994 Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63 793 807
9. S. Teitel J. O'Brien A. Brossi 1972 Alkaloids in mammalian tissue: 2. Synthesis of (+)-and (-)-/-substituted-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinolines J Med Chem 15 845 846
10. J.F. Jen M.F. Leu T.C. Yang 1998 Determination of hydroxyl radicals in an advanced oxidation process with salicylic acid trapping and liquid chromatography J Chromatogr A 796 283 288
11. +-induced apoptosis Eur J Neurosci 17 1563 1570
12. M. Naoi W. Maruyama Y. Akao H. Yi 2002 Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease Neurotoxicol Teratol 24 579 591
13. P.M. Kidd 2000 Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management Altern Med Rev 5 502 529
14. J. Sian D.T. Dexter A.J. Lees S. Daniel Y. Agid F. Javoy-Agid 1994 Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348 355
15. E. Sofic K. W. Lange K. Jellinger P. Riederer 1992 Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease Neurosci Lett 142 128 130
16. D. Kaur J. Andersen 2004 Does cellular iron dysregulation play a causative role in Parkinson's disease? Aging Res Rev 3 327 343
17. A. Pezzella M. d'Ischia A. Napolitano G. Misuraca G. Prota 1997 Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease J Med Chem 40 2211 2216
18. K. Jellinger W. Paulus I. Grundke-Iqbal P. Riederer M.B. Youdim 1990 Brain iron and ferritin in Parkinson's and Alzheimer's diseases J Neural Trans Park Dis Dement Sect 2 327 340
19. S. Hemdan G. Almazan 2006 Iron contributes to dopamine-induced toxicity in oligodendrocyte progenitors Neuropathol Appl Neurobiol 32 428 440
20. M. Sandler S.B. Carter K.R. Hunter G.M. Stern 1973 Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-dopa in man Nature 241 439 443
21. M. Naoi W. Maruyama G.M. Nagy 2004 Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains Neurotoxicology 25 193 204
22. W. Maruyama D. Nakahara P. Dostert T. Takahashi M. Naoi 1993 Naturally-occurring isoquinolines perturb monoamine metabolism in the brain: studies by in vivo microdialysis J Neural Transs 94 91 102
23. K. Matsubara M. Ota T. Takahashi W. Maruyama M. Naoi 1994 Structural studies of condensation products of biogenic amines as inhibitors of tryptophan hydroxylase Brain Res 655 121 127
24. M. Naoi W. Maruyama P. Dostert Y. Hashizume D. Nakahara T. Takahashi 1996 Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetra- hydroisoqunoline, Nmethyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies Brain Res 709 285 295
25. W. Maruyama T. Abe H. Tohgi P. Dostert M. Naoi 1996 A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid Ann Neurol 40 119 122
26. M. Naoi W. Maruyama Y. Akao H. Yi 2002 Mitochondria determine the survival and death in apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, and neuro-protection by propargylamines J Neural Transm 109 607 621